A Novel Balance Program to Improve Balance in People With Parkinson's Disease: A Randomized Control Trial

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this exploratory single-blinded randomized control trial is to explore the effects of a lateral stepping program integrated into an existing community-based group exercise program for people with PD. The researchers hypothesize that participation in a lateral stepping program a minimum of 2 times/week for 8 weeks, in addition to RSB class participation, will decrease fall risk factors, increase balance confidence, and decrease fear of falling in participants in the experimental group compared to the control group. The researchers also hypothesize that the integration of this program into an existing community-based RSB program will be deemed feasible as shown by the number of sessions attended by each participant and their satisfaction

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 85
Healthy Volunteers: f
View:

• A diagnosis of idiopathic PD stages I, II, or III of the Hoehn and Yahr scale

• 50-85 years inclusive

• Subjects must be enrolled in RSB at NY Tech and attend at least 1 day per week for a minimum of 4 weeks prior to the first baseline assessment

• English speaking.

• Stable PD medication regime.

Locations
United States
New York
New York Institute of Technology
RECRUITING
Old Westbury
Contact Information
Primary
Michael Tautonico, DPT
mtautoni@nyit.edu
9173651437
Time Frame
Start Date: 2023-09-20
Estimated Completion Date: 2024-07
Participants
Target number of participants: 30
Treatments
Experimental: Decrease fear of falling
Experimental: Decrease the number of fall risk factors
Experimental: Increase balance confidence
Experimental: prove feasible to integrate into an existing community group exercise program
Related Therapeutic Areas
Sponsors
Leads: New York Institute of Technology

This content was sourced from clinicaltrials.gov